Literature DB >> 8406893

Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Y Zhan1, C Cheers.   

Abstract

Depletion of endogenous gamma interferon (IFN-gamma) with anti-IFN-gamma monoclonal antibody resulted in increased numbers of Brucella abortus in the spleen and liver of infected CBA mice. This increase was accompanied by a decrease in splenomegaly and a lower proportion of macrophages in the spleen. Furthermore, treatment of recipient mice with anti-IFN-gamma antibody blocked the adoptive transfer of resistance with immune T cells. Together, the results indicated that endogenous IFN-gamma plays an important role in mediating resistance to primary and secondary Brucella infection.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8406893      PMCID： PMC281252          DOI： 10.1128/iai.61.11.4899-4901.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.

Authors:  M Khor; D B Lowrie; A R Coates; D A Mitchison
Journal:  Br J Exp Pathol       Date:  1986-08

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 3.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

4.  In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection.

Authors:  H Pavlov; M Hogarth; I F McKenzie; C Cheers
Journal:  Cell Immunol       Date:  1982-07-15       Impact factor: 4.868

5.  Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.

Authors:  S M Jones; A J Winter
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

7.  Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.

Authors:  M G Stevens; G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Effects of cytokines on intracellular growth of Brucella abortus.

Authors:  X Jiang; C L Baldwin
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens.

Authors:  T Springer; G Galfrè; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

10.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205
View more
  74 in total

1.  Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice.

Authors:  Paolo Pasquali; Rosanna Adone; Louis C Gasbarre; Claudia Pistoia; Franco Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

Authors:  L E Lindler; T L Hadfield; B D Tall; N J Snellings; F A Rubin; L L Van De Verg; D Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

Authors:  S Segura; C Gamazo; J M Irache; S Espuelas
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice.

Authors:  Wenpeng Gu; Xin Wang; Haiyan Qiu; Buyun Cui; Shiwen Zhao; Han Zheng; Yuchun Xiao; Junrong Liang; Ran Duan; Huaiqi Jing
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

5.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

6.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.

Authors:  J Xu; Y Qiu; M Cui; Y Ke; Q Zhen; X Yuan; Y Yu; X Du; J Yuan; H Song; Z Wang; G Gao; S Yu; Y Wang; L Huang; Z Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-15       Impact factor: 3.267

8.  Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.

Authors:  Hortensia García Rolán; Renée M Tsolis
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51.

Authors:  R Vemulapalli; A J Duncan; S M Boyle; N Sriranganathan; T E Toth; G G Schurig
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.